Want to see IN:ZOTA full AI Analyst Report?
ZOTA Stock Chart & Stats
₹1533.20
₹23.30(2.41%)
At close: 4:00 PM EST
₹1533.20
₹23.30(2.41%)
Day’s Range― - ―
52-Week Range₹1,026.20 - ₹1,740.00
Previous CloseN/A
Volume255.13K
Average Volume (3M)68.23K
Market Cap
₹38.80B
Enterprise Value₹44.91K
Total Cash (Recent Filing)₹955.74M
Total Debt (Recent Filing)₹2.70B
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.08%
Share Statistics
EPS (TTM)-18.77
Shares Outstanding30,332,655
10 Day Avg. Volume83,032
30 Day Avg. Volume68,228
Financial Highlights & Ratios
PEG Ratio-5.04
Price to Book (P/B)5.05
Price to Sales (P/S)6.51
P/FCF Ratio-18.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-13.8
Revenue Forecast (FY)₹9.31B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained high top-line expansion signals strong market traction and product uptake across channels. Durable revenue momentum supports investment in manufacturing, distribution and new product introductions, enabling scale benefits and the potential to improve unit economics as operations mature.
Manageable Leverage On PaperA moderate debt-to-equity ratio driven by equity growth gives the company breathing room to fund operations and expansions without extreme leverage on paper. This structural balance-sheet buffer can support strategic investments and external funding access while the business works to restore profitability.
Integrated, Diversified Business ModelVertical capabilities in development, manufacturing, marketing and distribution across branded and generic portfolios diversify revenue sources and reduce single-product risk. A presence in domestic and export markets provides structural resilience and multiple growth channels over the medium term.
Bears Say
Margin DeteriorationSharp compression in gross and net margins indicates worsening unit economics from pricing, mix or cost pressures that are currently overwhelming revenue gains. Sustained margin weakness undermines profitability potential and will require structural fixes to restore returns and cash generation.
Persistent Cash BurnLarge and persistent negative operating and free cash flows create reliance on external financing and raise execution risk. Until operations turn cash-positive, this structural cash burn limits reinvestment flexibility, increases vulnerability to funding market conditions, and pressures long-term sustainability.
Rising Absolute DebtRapid growth in absolute debt increases interest and refinancing burdens, especially while earnings are negative. Even with moderate ratios, the higher debt stock amplifies risk during prolonged losses and cash deficits, potentially constraining strategic options and increasing financial stress over months.
Zota Health Care Ltd. News
ZOTA FAQ
What was Zota Health Care Ltd.’s price range in the past 12 months?
Zota Health Care Ltd. lowest stock price was ₹1026.20 and its highest was ₹1740.00 in the past 12 months.
What is Zota Health Care Ltd.’s market cap?
Zota Health Care Ltd.’s market cap is ₹38.80B.
When is Zota Health Care Ltd.’s upcoming earnings report date?
Zota Health Care Ltd.’s upcoming earnings report date is Aug 10, 2026 which is in 6 days.
How were Zota Health Care Ltd.’s earnings last quarter?
Zota Health Care Ltd. released its earnings results on May 22, 2026. The company reported -₹4.13 earnings per share for the quarter, beating the consensus estimate of -₹18.4 by ₹14.27.
Is Zota Health Care Ltd. overvalued?
According to Wall Street analysts Zota Health Care Ltd.’s price is currently Overvalued.
Does Zota Health Care Ltd. pay dividends?
Zota Health Care Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.08%. See more information on Zota Health Care Ltd. dividends here
What is Zota Health Care Ltd.’s EPS estimate?
Zota Health Care Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zota Health Care Ltd. have?
Zota Health Care Ltd. has 30,332,655 shares outstanding.
What happened to Zota Health Care Ltd.’s price movement after its last earnings report?
Zota Health Care Ltd. reported an EPS of -₹4.13 in its last earnings report, beating expectations of -₹18.4. Following the earnings report the stock price went down -1.949%.
Which hedge fund is a major shareholder of Zota Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:ZOTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zota Health Care Ltd.
Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
Technical Analysis
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Panacea Biotec Limited
―
Supriya Lifescience Limited
―
OneSource Specialty Pharma Limited
―